Neurofibromatosis and Tuberous Sclerosis

50


Neurofibromatosis and Tuberous Sclerosis





Neurofibromatosis Type 1 (von Recklinghausen Disease)



Incidence of approximately 1 in 3000 births.


The NF1 tumor suppressor gene encodes the neurofibromin protein, which negatively regulates the RAS-mitogen-activated protein kinase (MAPK) pathway that promotes cell survival and proliferation.


Patients with NF1 have a constitutive (germline) NF1 mutation plus a somatic ‘second hit’ mutation inactivating the other copy of the gene in affected tissues (e.g. Schwann cells in neurofibromas, melanocytes in café-au-lait macules [CALMs]).


The major clinical features of NF1 are outlined in Table 50.1 and depicted in Figs. 50.150.5; Fig. 50.6 shows the time course of their development.








Apr 22, 2016 | Posted by in Dermatology | Comments Off on Neurofibromatosis and Tuberous Sclerosis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access